CLINICAL TRIALS AND OBSERVATIONS Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma
نویسندگان
چکیده
1Department of Haematology, University College London Cancer Institute; 2University College London Institute of Nuclear Medicine, University College Hospital London; 3Department of Haematology, University College Hospital London National Health Service Trust; 4Department of Haematology, Royal Free Campus, University College London Medical School; 5Cancer Research UK and University College London Cancer Trials Centre; and 6Department of Immunology, Royal Free Campus, University College London Medical School, London, United Kingdom
منابع مشابه
CLINICAL TRIALS AND OBSERVATIONS Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma
This study was set up to demonstrate whether prognostic classification based on the secondary age-adjusted International Prognostic Index (sAA-IPI) for recurring aggressive non-Hodgkin lymphoma (NHL) or the prognostic score for recurring Hodgkin lymphoma (HL) can be improved by including the midtreatment results of fluorine-18-fluorodeoxy-glucose–positron emission tomography (FDG-PET). Clinical...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
Autologous stem cell transplantation (ASCT) improves survival in patients with previously untreated multiple myeloma (MM) and relapsed, chemotherapy-sensitive, aggressive non-Hodgkin lymphoma (NHL). Lower relapse rates seen in allogeneic stem cell transplantation have been related to early absolute lymphocyte count (ALC) recovery as a manifestation of early graft-verus-tumor effect. In ASCT, th...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
This study reports outcomes of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning (RIC) in 186 patients with chronic myeloid leukemia (CML) from the European Group for Blood and Marrow Transplantation (EBMT). The median age was 50 years, and 64% were in first chronic phase (CP1), CP2 13%, accelerated phase 17%, and blast crises 6%. The median EBMT transplant ...
متن کاملBrentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.
IMPORTANCE The prognosis of advanced cutaneous T-cell lymphoma (CTCL), including Sézary syndrome and mycosis fungoides (MF), is poor. So far, no curative option apart from allogeneic stem cell transplantation is available. Large cell transformation often hallmarks cases with a more aggressive clinical course, and large tumor cells may express CD30. Recently, brentuximab vedotin, a conjugate of ...
متن کاملCLINICAL TRIALS AND OBSERVATIONS The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma
This is a phase 2 study to assess the role of tumor histogenesis (subtype), fluorodeoxyglucose positron emission tomography (FDG-PET), and short-course etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin with dosedense rituximab (SC-EPOCH-RR) in newly diagnosed HIV-associated CD20 diffuse large B-cell lymphoma. Patients received a minimum of 3 and a maximum of 6 cycles with 1 ...
متن کامل